InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the complete record of transactions filed by Biondi Paul. Insider active across 1 company, notably Seres Therapeutics, Inc.. In total, 1 reports have been logged. History available since 5 July 2022. The latest transaction was disclosed on 5 July 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration